HTA
VPHM

Haber Trilix Advisors’s VIROPHARMA INC VPHM Stock Holding History

Haber Trilix Advisors’s Portfolio VPHM Stock Details VPHM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$112K Buy
+3,900
New +$103K 0.01% 168

Other funds holding VPHM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Haber Trilix Advisors's VPHM Position: Q2 2013 in Review

Haber Trilix Advisors opened a new position in VIROPHARMA INC (VPHM) in Q2 2013: 3,900 shares worth $112K. The stake represents 0.01% of the portfolio and ranks #168 among its holdings.

174 funds tracked by Wall St. Rank hold VPHM as of Q2 2013.

  • Haber Trilix Advisors held 3,900 shares of VIROPHARMA INC worth $112K as of Q2 2013.
  • VIROPHARMA INC was a new Haber Trilix Advisors position in Q2 2013.
  • VIROPHARMA INC made up 0.01% of Haber Trilix Advisors's portfolio in Q2 2013, its #168 holding.
  • 174 funds tracked by Wall St. Rank held VIROPHARMA INC as of Q2 2013.

Based on Haber Trilix Advisors's 13F filing for Q2 2013, filed 14 Aug 2013.